Cite

HARVARD Citation

    Peña, M. et al. (n.d.). EP-2151 Intermediate-risk prostate cancer with EBRT plus permanent 125-I seeds. Long term results. Radiotherapy and oncology. pp. S1190-. [Online]. 
  
Back to record